arginyl-glycyl-aspartic acid has been researched along with Body Weight in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Francese, G; Lewrick, F; Rössler, J; Scherzinger-Laude, K; Schönherr, C; Süss, R | 1 |
Hashimoto, R; Hatta, T; Inoue, T; Jahan, E; Matsumoto, A; Otani, H; Rafiq, AM; Udagawa, J | 1 |
Jiang, J; Lv, L; Lv, M; Shao, F; Wang, J; Wang, Y; Zheng, Y | 1 |
Luo, CL; Sun, QS; Wang, JC; Zhang, Q; Zhao, H | 1 |
Elmlinger, MW; Hoeflich, A; Jehle, PM; Lahm, H; Reisinger, R; Renner-Müller, I; Russo, VC; Schuett, B; Vargas, GA; Wolf, E | 1 |
Hayakawa, T; Mayumi, T; Mizuguchi, H; Mizuno, N; Okada, N; Okada, Y; Takahashi, K | 1 |
Hayakawa, T; Mayumi, T; Mizuguchi, H; Nakagawa, S; Okada, N; Okada, Y | 1 |
Intengan, HD; Li, JS; Schiffrin, EL; Thibault, G | 1 |
Barone, FC; Feng, Y; Feuerstein, GZ; Gerstenhaber, JA; Lelkes, PI; Li, J; Marcinkiewicz, C; Rosenbaum-Halevi, D; Sternberg, M | 1 |
9 other study(ies) available for arginyl-glycyl-aspartic acid and Body Weight
Article | Year |
---|---|
Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906).
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Survival; Drug Carriers; Epothilones; Female; Human Umbilical Vein Endothelial Cells; Humans; Integrin alphaVbeta3; Kaplan-Meier Estimate; Liposomes; Mice; Mice, SCID; Neuroblastoma; Oligopeptides; Rhabdomyosarcoma; Xenograft Model Antitumor Assays | 2013 |
In vivo analysis of Arg-Gly-Asp sequence/integrin α5β1-mediated signal involvement in embryonic enchondral ossification by exo utero development system.
Topics: Animals; Antibodies; Body Weight; Cell Differentiation; Cell Proliferation; Chondrocytes; Crown-Rump Length; Embryo, Mammalian; Embryonic Development; Extremities; Female; Growth Plate; Injections; Integrin alpha5beta1; Mice; Oligopeptides; Osteogenesis; Signal Transduction | 2014 |
The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
Topics: Amino Acid Motifs; Angiogenesis Inhibitors; Animals; Apoptosis; Body Weight; Carcinoma, Squamous Cell; Cell Line, Tumor; Fish Proteins; Fish Venoms; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Lampreys; Laryngeal Neoplasms; Marine Toxins; Mice, Nude; Microvessels; Oligopeptides; Random Allocation; Recombinant Proteins; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Body Weight; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Fluorescence; Humans; Inhibitory Concentration 50; Injections, Intravenous; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Ovarian Neoplasms; Paclitaxel; Xenograft Model Antitumor Assays | 2009 |
Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP-2 in vivo.
Topics: Amino Acid Motifs; Animals; Body Weight; Cell Membrane; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Membrane Proteins; Mice; Mice, Transgenic; Oligopeptides; Organ Size; Point Mutation | 2002 |
Optimization of antitumor efficacy and safety of in vivo cytokine gene therapy using RGD fiber-mutant adenovirus vector for preexisting murine melanoma.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Body Weight; Cytokines; Female; Genetic Therapy; Genetic Vectors; Injections, Intralesional; Interferon-gamma; Interleukin-12; Killer Cells, Natural; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oligopeptides; Spleen; Time Factors; Transduction, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2004 |
Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma.
Topics: Adenoviridae; Animals; Body Weight; DNA-Binding Proteins; Gene Transfer Techniques; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Humans; Injections, Intralesional; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; Oligopeptides; Promoter Regions, Genetic; Simplexvirus; Skin Neoplasms; Telomerase; Thymidine Kinase; Transduction, Genetic; Transgenes; Tumor Cells, Cultured | 2005 |
Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Collagen; Elastin; Fosinopril; Hypertension; Integrins; Irbesartan; Male; Mesenteric Arteries; Oligopeptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vascular Resistance | 1999 |
Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, particle distribution and excretion studies (part IV).
Topics: Animals; Behavior, Animal; Biocompatible Materials; Bioengineering; Body Weight; Feces; Fluorescence; Male; Nanodiamonds; Organ Size; Organ Specificity; Particle Size; Peptides; Rats, Sprague-Dawley; Snake Venoms; Solubility; Survival Analysis; Time Factors; Tissue Distribution | 2019 |